Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
January 31, 2022
Baricitinib: Two Birds with One Stone
Fen Saj, Smita Kayal, Biswajit Dubashi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
October 29, 2024
Generic Dabigatran for Cancer-Associated Venous Thromboembolism: Real-World Data
Fen Saj, Smita Kayal, Biswajit Dubashi, et al.
The National Medical Journal of India
|
October 24, 2024
Palbociclib: A novel and effective therapy for advanced liposarcoma
Fen Saj, Deepak Dabkara, Siddharth Turkar, et al.
Journal of Cancer Research and Therapeutics
|
December 31, 2025
Real-world outcomes of low-dose nivolumab in advanced malignancies
Fen Saj, Rachna Sahu, Senthilkumar Ramasamy, et al.
Ecancermedicalscience
|
October 18, 2024
Management of <i>BRCA</i>-associated breast cancer patients in low and middle-income countries: a review
Fen Saj, Shona Nag, Nita Nair, et al.
Cancer
|
June 14, 2024
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
Fen Saj, Y Linda Wu, Shubham Pant, et al.
Hematology/Oncology Clinics of North America
|
June 10, 2026
Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging Horizons
Jorge Adeva, Valerie S Kalluri, Fen Saj, et al.
Blood Cancer Journal
|
March 25, 2023
Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study
Fen Saj, Yadav Nisha, Prasanth Ganesan, et al.
Investigational New Drugs
|
February 12, 2026
Phase I results of a multicenter, open-label, dose de-escalation and expansion study of gemcitabine and cisplatin with ivosidenib or pemigatinib for advanced cholangiocarcinoma
Fen Saj, Tanios S Bekaii-Saab, Milind Javle, et al.
The Oncologist
|
October 28, 2025
Economic and clinical outcomes among patients with cholangiocarcinoma receiving pemigatinib with or without history of cancer of unknown primary
Sumit Verma, Alejandro Hughes, Nicole M Engel-Nitz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
January 31, 2022
Baricitinib: Two Birds with One Stone
Fen Saj, Smita Kayal, Biswajit Dubashi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
October 29, 2024
Generic Dabigatran for Cancer-Associated Venous Thromboembolism: Real-World Data
Fen Saj, Smita Kayal, Biswajit Dubashi, et al.
The National Medical Journal of India
|
October 24, 2024
Palbociclib: A novel and effective therapy for advanced liposarcoma
Fen Saj, Deepak Dabkara, Siddharth Turkar, et al.
Journal of Cancer Research and Therapeutics
|
December 31, 2025
Real-world outcomes of low-dose nivolumab in advanced malignancies
Fen Saj, Rachna Sahu, Senthilkumar Ramasamy, et al.
Ecancermedicalscience
|
October 18, 2024
Management of <i>BRCA</i>-associated breast cancer patients in low and middle-income countries: a review
Fen Saj, Shona Nag, Nita Nair, et al.
Cancer
|
June 14, 2024
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers
Fen Saj, Y Linda Wu, Shubham Pant, et al.
Hematology/Oncology Clinics of North America
|
June 10, 2026
Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging Horizons
Jorge Adeva, Valerie S Kalluri, Fen Saj, et al.
Blood Cancer Journal
|
March 25, 2023
Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study
Fen Saj, Yadav Nisha, Prasanth Ganesan, et al.
Investigational New Drugs
|
February 12, 2026
Phase I results of a multicenter, open-label, dose de-escalation and expansion study of gemcitabine and cisplatin with ivosidenib or pemigatinib for advanced cholangiocarcinoma
Fen Saj, Tanios S Bekaii-Saab, Milind Javle, et al.
The Oncologist
|
October 28, 2025
Economic and clinical outcomes among patients with cholangiocarcinoma receiving pemigatinib with or without history of cancer of unknown primary
Sumit Verma, Alejandro Hughes, Nicole M Engel-Nitz, et al.
Page
of 2